Quidel Corp. (QDEL) CEO Douglas C. Bryant Sells 69,168 Shares of Stock
Quidel Corp. (NASDAQ:QDEL) CEO Douglas C. Bryant sold 69,168 shares of Quidel Corp. stock in a transaction that occurred on Friday, September 30th. The stock was sold at an average price of $21.76, for a total transaction of $1,505,095.68. Following the completion of the sale, the chief executive officer now directly owns 291,121 shares of the company’s stock, valued at $6,334,792.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Shares of Quidel Corp. (NASDAQ:QDEL) opened at 22.09 on Friday. Quidel Corp. has a 12 month low of $13.21 and a 12 month high of $23.94. The company’s 50-day moving average is $21.73 and its 200-day moving average is $19.11. The stock’s market capitalization is $715.54 million.
Quidel Corp. (NASDAQ:QDEL) last issued its quarterly earnings results on Wednesday, July 27th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.14. Quidel Corp. had a negative net margin of 6.59% and a negative return on equity of 1.06%. The company earned $39.10 million during the quarter, compared to analysts’ expectations of $37.98 million. During the same quarter in the previous year, the company earned ($0.14) EPS. Quidel Corp.’s revenue was up 11.1% on a year-over-year basis. Equities research analysts expect that Quidel Corp. will post ($0.14) earnings per share for the current fiscal year.
Large investors have recently modified their holdings of the company. A.R.T. Advisors LLC boosted its stake in shares of Quidel Corp. by 196.5% in the first quarter. A.R.T. Advisors LLC now owns 45,570 shares of the company’s stock valued at $786,000 after buying an additional 30,200 shares in the last quarter. Aristotle Capital Boston LLC boosted its stake in shares of Quidel Corp. by 3.2% in the second quarter. Aristotle Capital Boston LLC now owns 266,364 shares of the company’s stock valued at $4,757,000 after buying an additional 8,338 shares in the last quarter. Norges Bank acquired a new stake in shares of Quidel Corp. during the fourth quarter valued at approximately $8,736,000. Kennedy Capital Management Inc. acquired a new stake in shares of Quidel Corp. during the first quarter valued at approximately $1,012,000. Finally, Menta Capital LLC boosted its stake in shares of Quidel Corp. by 19.9% in the first quarter. Menta Capital LLC now owns 39,804 shares of the company’s stock valued at $687,000 after buying an additional 6,600 shares in the last quarter. Institutional investors own 94.28% of the company’s stock.
Several analysts have recently issued reports on QDEL shares. Zacks Investment Research cut shares of Quidel Corp. from a “buy” rating to a “hold” rating in a research note on Saturday, July 23rd. Canaccord Genuity reissued a “hold” rating and set a $22.00 price objective on shares of Quidel Corp. in a research note on Friday, July 29th. Finally, Raymond James Financial Inc. raised shares of Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price objective for the company in a research note on Monday, June 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company’s stock. Quidel Corp. currently has a consensus rating of “Hold” and a consensus target price of $21.58.
About Quidel Corp.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.
Receive News & Stock Ratings for Quidel Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corp. and related stocks with our FREE daily email newsletter.